Phacilitate Leaders World

Conference speakers

Conference speakers

We’re hard at work finalising the agenda and speaker panel for Phacilitate Leaders World 2019. If would like to speak or submit an abstract please get in touch with Kim Barnes.

Loading
  • Joy Aho

    Joy Aho

    Senior Product Manager for Cell and Gene Therapy, Bio Techne
  • Ernesto Algaba Reyes

    Ernesto Algaba Reyes

    Partner, Mexico City, Hogan Lovells
  • Evren Alici

    Evren Alici

    CEO; Director, Cell & Gene Therapy Centre, Vycellix; Karolinska Institutet
  • Julie Allickson

    Julie Allickson

    Director, Regenerative Medicine Clinical Center, Wake Forest School of Medicine
  • Fabrisia Ambrosio

    Fabrisia Ambrosio

    Associate Professor, Department of Physical Medicine & Rehabilitation / Director of Rehabilitation, University of Pittsburgh / UPMC International
  • Steve Anderson

    Steve Anderson

    Chief Scientific Officer, Covance
  • Judith Arcidiacono

    Judith Arcidiacono

    International Regulatory Expert & Standards Liaison, Center for Biologics Evaluation and Research, Food and Drug Administration
  • Takashi Asada

    Takashi Asada

    Professor, Institute for Frontier Life and Medical Sciences, Kyoto University
  • Anthony Atala, MD

    Anthony Atala, MD

    Professor and Director, Wake Forest Regenerative Medicine Institute, Wake Forest School of Medicine
  • Usman Azam

    Usman Azam

    President & CEO, Tmunity Therapeutics
  • David Backer

    David Backer

    Head of Commercial Development, Gene Editing and Novel Modalities , MilliporeSigma
  • Jacqueline Barry

    Jacqueline Barry

    Chief Clinical Officer, Cell and gene Therapy Catapult
  • Nina Bauer

    Nina Bauer

    VP Business Development, FloDesign Sonics
  • Reni Benjamin

    Reni Benjamin

    Managing Director, Biotechnology Equity Research, Raymond James & Associates, Inc
  • Alexey Bersenev

    Alexey Bersenev

    Director, Cell Therapy Labs, Yale-New Haven Hospital, Yale University
  • Ravi Bhatia

    Ravi Bhatia

    Scientific Director, Johnson & Johnson
  • Barbara Binzak Blumenfeld

    Barbara Binzak Blumenfeld

    Shareholder / Member, Buchanan Ingersoll & Rooney PC / AARM Etjhics and Policy Committee
  • John Bishai

    John Bishai

    Director, Healthcare Investment Banking, Wells Fargo Securities
  • Tony Bizou Liu

    Tony Bizou Liu

    Executive Director, CEO, CFO, Cellular Biomedicine Group
  • Greg Bonfiglio

    Greg Bonfiglio

    Founder & Managing Partner, Proteus, LLC
  • Maria Bonneville

    Maria Bonneville

    Vice President of Administration, Executive Director to the CIRM Governing Board, Californian Institute of Regenerative Medicine
  • Christopher Bravery

    Christopher Bravery

    Director, Advanced Biologicals Ltd
  • Steven Breazzano, PhD

    Steven Breazzano, PhD

    Analyst, Casdin Capital
  • Kelvin Brockbank

    Kelvin Brockbank

    Research Professor of Bioengineering / Adjunct Professor, Department of Regenerative Medicine & Cell Biology, Clemson University / Medical University of South Carolina
  • Brian Bronk

    Brian Bronk

    Head of External Innovation, Rare Diseases, Global Business Development & Licensing, Sanofi
  • Bruce Bunnell

    Bruce Bunnell

    Professor & Director, Tulane Center for Stem Cell Research & Regenerative Medicine, Tulane University
  • Terry Burns

    Terry Burns

    Neurosurgeon, Mayo Clinic
  • Lambert Busque

    Lambert Busque

    Chief Medical Officer, C3i
  • Neil Canavan

    Neil Canavan

    Author, A Cure Within
  • Arnold Caplan, PhD

    Arnold Caplan, PhD

    Professor of Biology and Director of the Skeletal Research Center, Case Western Reserve University
  • Joy Cavagnaro

    Joy Cavagnaro

    President, Access BIO
  • Kyle J. Cetrulo

    Kyle J. Cetrulo

    Co-Founder & CEO / President & Founder, Auxocell Laboratories, Inc / Perinatal Stem Cells Society
  • Saswati Chatterjee

    Saswati Chatterjee

    Professor, Department of Surgery, City of Hope
  • Theresa Chen

    Theresa Chen

    Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Tissues and Advanced Therapies (OTAT) Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA)
  • Li Chen

    Li Chen

    Head of Human Liver Cell Lab, UCSD
  • Vijay Chiruvulu

    Vijay Chiruvulu

    VP of Global Process Development - Cell Therapy, Kite Pharma (A Gilead Company)
  • George Christ

    George Christ

    Professor of Biomedical Engineering & Orthopaedic Surgery, Mary Muilenberg Stamp Professor of Orthopaedic Research, Director of Basic and Translational Research in Orthopaedic Surgery, University of Virginia
  • Dominic Clarke

    Dominic Clarke

    Global Head of Cell Therapy, Hemacare
  • Diego Correa

    Diego Correa

    Assistant Professor, Diabetes Research Institute, Cell Transplant Center and Department of Orthopedics - UHealth Sport Medicine Institute, University of Miami Miller School of Medicine
  • David Courtman

    David Courtman

    Assistant Professor, University of Ottawa
  • Desiree Cox, MD, PhD

    Desiree Cox, MD, PhD

    Founder and CEO, The HEALinc and HEALinc Future Health Summit
  • Jeremy Cress

    Jeremy Cress

    Director of Operations, Fibrocell Science
  • Richard D’Amico

    Richard D’Amico

    Past President, American Society for Plastic Surgeons
  • Salmaan Dalvi

    Salmaan Dalvi

    Board of Directors, Cord Blood Association
  • Sybil Danby

    Sybil Danby

    Senior Director Business Development, Paragon Bioservices, Inc
  • Gregory Daniel

    Gregory Daniel

    Deputy Center Director, Duke-Margolis Center for Health Policy
  • Anthony Davies

    Anthony Davies

    President, Dark Horse Consulting
  • Paolo De Coppi

    Paolo De Coppi

    Consultant Paediatric Surgeon / Reader & Head of Stem Cells & Regenerative Medicine, Great Ormond Street / UCL

 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK